These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36347499)

  • 1. COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
    Ferreira FB; Mourato M; Bragança S; Paulo JB; Sismeiro R; Pereira A; Mónica AN; Lourenço LC; Cardoso M
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102048. PubMed ID: 36347499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
    Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
    Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corona again? SSC after a severe COVID-disease.
    Arnstadt B; Zillinger C; Treitl M; Allescher HD
    Z Gastroenterol; 2021 Dec; 59(12):1304-1308. PubMed ID: 34666402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid progress of acute suppurative cholangitis to secondary sclerosing cholangitis sequentially followed-up by endoscopic retrograde cholangiography.
    Tanaka Y; Koshiyama H; Nakao K; Makita Y; Kobayashi Y; Yoshida Y; Kimura M; Adachi Y
    Endoscopy; 2001 Jul; 33(7):633-5. PubMed ID: 11473338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.
    Bauer U; Pavlova D; Abbassi R; Lahmer T; Geisler F; Schmid RM; Ehmer U
    Clin J Gastroenterol; 2022 Dec; 15(6):1124-1129. PubMed ID: 35953614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic Characterization and Outcome of COVID-19 Patients with Secondary Sclerosing Cholangitis: A Case Series of a Tertiary Center.
    Hofstetter P; Zuber-Jerger I; Mehrl A; Graf B; Lunz D; Lubnow M; Müller T; Schmid S; Müller M; Kandulski A
    J Gastrointestin Liver Dis; 2024 Jun; 33(2):218-225. PubMed ID: 38944874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.
    Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER
    Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary sclerosing cholangitis.
    Ruemmele P; Hofstaedter F; Gelbmann CM
    Nat Rev Gastroenterol Hepatol; 2009 May; 6(5):287-95. PubMed ID: 19404269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing cholangitis and liver cirrhosis after extrabiliary infections: report on three cases.
    Scheppach W; Druge G; Wittenberg G; Mueller JG; Gassel AM; Gassel HJ; Richter F
    Crit Care Med; 2001 Feb; 29(2):438-41. PubMed ID: 11246328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients.
    Gelbmann CM; Rümmele P; Wimmer M; Hofstädter F; Göhlmann B; Endlicher E; Kullmann F; Langgartner J; Schölmerich J
    Am J Gastroenterol; 2007 Jun; 102(6):1221-9. PubMed ID: 17531010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis.
    Genève J; Dubuc N; Mathieu D; Zafrani ES; Dhumeaux D; Métreau JM
    J Hepatol; 1990 Sep; 11(2):196-9. PubMed ID: 2254629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.
    Ludwig DR; Anderson MA; Itani M; Sharbidre KG; Lalwani N; Paspulati RM
    Abdom Radiol (NY); 2023 Jan; 48(1):151-165. PubMed ID: 35585354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.
    Miura F; Asano T; Amano H; Yoshida M; Toyota N; Wada K; Kato K; Takada T; Fukushima J; Kondo F; Takikawa H
    World J Gastroenterol; 2009 Mar; 15(11):1394-7. PubMed ID: 19294772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endoscopic treatment in patients with secondary sclerosing cholangitis.
    Zhang CC; Sauer P; Rupp C
    J Gastroenterol Hepatol; 2022 Oct; 37(10):2011-2018. PubMed ID: 35933581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients.
    Leonhardt S; Jürgensen C; Frohme J; Grajecki D; Adler A; Sigal M; Leonhardt J; Voll JM; Kruse JM; Körner R; Eckardt KU; Janssen HJ; Gebhardt V; Schmittner MD; ; Frey C; Müller-Ide H; Bauer M; Thibeault C; Kurth F; Sander LE; Müller T; Tacke F
    Hepatol Int; 2023 Dec; 17(6):1610-1625. PubMed ID: 37119516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.